Clinical Trials Sponsored by Peking University

Total 223876 results

Peking University

Unknown

Trial of Surufatinib Combined With JS001 in the Treatment of Advanced Solid Tumors

Solid Tumor

China
Peking University

Completed

Computed Tomography (CT) Reconstruction for Axillary Lymph Node Structure (CTREP)

Invasive Breast Cancer

China
Peking University

Withdrawn

PD-1 Knockout Engineered T Cells for Castration Resistant Prostate Cancer

Hormone Refractory Prostate Cancer

China
Peking University

Withdrawn

PD-1 Knockout Engineered T Cells for Muscle-invasive Bladder Cancer

Invasive Bladder Cancer Stage IV

China
Peking University

Unknown

Metformin in Combined With Cisplatin Plus Paclitaxel With Advanced Esophageal Squamous Cell Carcinoma (ECMTPneo) (ECMTPneo)

Esophageal Squamous Cell Carcinoma

China
Peking University

Completed

The Efficacy and Safety of PEG-rhG-CSF（Pegylated Recombinant Human Granulocyte Colony Stimulating Factor)in Patients With Breast Cancer Who Were Treated With Intensive Chemotherapy

Breastcancer

China
Peking University

Unknown

PD1 Combined With Apatinib in Patients With Relapsed or Refractory NK/T Cell Lymphoma

NK/T-cell Lymphoma
Peking University

Unknown

Nab-paclitaxel Plus S-1(AS) Versus Nab-paclitaxel Plus Gemcitabine(AG) in Patients With Advanced Pancreatic Cancer (ASAGPAC)

Pancreatic Cancer

China
Peking University

Unknown

Real World Evidence for the Cycle of Neoadjuvant Chemotherapy in Gastric Cancer With Shared Decision Making (RECOMMEND)

Gastric Cancer

China
Peking University

Unknown

Cetuximab in Combination With Paclitaxel Plus Cisplatin Versus Paclitaxel Plus Cisplatin Alone for the First-line Treatment of Metastatic Esophageal Squamous Cell Carcinoma

Chemotherapy Effect | Esophageal Cancer, Squamous Cell | Cetuximab Effect

China
Peking University

Unknown

Psychosocial Screening for Neuroendocrine Tumor Patients

Neuroendocrine Tumors

China
Peking University

Unknown

Study to Evaluate the Efficiency of FOLFIRI as Seconde-line Chemotherapy in Neuroendocrine Carcinoma

Neuroendocrine Carcinoma

China
Peking University

Unknown

Prophylactic Use of Entecavir for HBsAg Negative/HBcAb Positive/Hepatitis B Virus DNA Negative Patients With Lymphoma

Hepatitis B

China
Peking University

Unknown

Study of Standard and Individualized Treatment Model for Relapse and Refractory Lymphatic System Malignant Tumors

Lymphoma

China
Peking University

Unknown

PEG-rhG-CSF in Lymphoma Patients After Autologous Hematopoietic Stem Cell Transplantation

Lymphoma

China
Peking University

Unknown

Study of I-125 Brachytherapy Versus Intensity-modulated Radiation Therapy to Treat Inoperable Salivary Gland Cancer

Salivary Gland Cancer

China
Peking University

Completed

Effect of Antenatal Iron-contained Multiple Micronutrient Supplementation, Cesarean Delivery, and CDMR on Child Health

Anemia | Overweight/Obesity | Mental Development

China
Peking University

Completed

Trial of ABI-007 Plus S-1 as Second-line Chemotherapy in Advanced Gastric Cancer Patients

Gastric Adenocarcinoma

China
Peking University

Unknown

Compare Different Response Evaluations to Neoadjuvant Chemotherapy for Gastric Cancer

Gastric Cancer

China
Peking University

Completed

Hepatitis B Virus Reactivation After Withdrawal of Prophylactic Antiviral Therapy in Lymphoma Patients

Lymphoma | Hematologic Diseases | Hepatitis B | Hepatitis

China
Peking University

Unknown

Study on Neoadjuvant Chemotherapy for Advanced Gastric Cancer

Advanced Gastric Carcinoma

China
Peking University

Unknown

The Effect of Postoperative Therapy on the Quality of Life of Patients With Early Cervical Cancer Research

Uterine Cervical Neoplasms
Peking University

Unknown

Phase I Trial of Intraperitoneal Bevacizumab in Refractory Malignant Ascites

Refractory Malignant Ascites

China
Peking University

Unknown

HER2 Positive CTC in Advanced Gastric Cancer (AGC-HER2CTC)

HER2 Positive Advanced Gastric Cancer

China
Peking University

Completed

Efficacy and Safety Study of Yunnan Baiyao on Minor Recurrent Aphthous Stomatitis

Recurrent Aphthous Stomatitis
Peking University

Unknown

Nimotuzumab Plus Paclitaxel and Cisplatin as 1st Line Treatment for Esophageal Squamous Cell Cancer

Esophageal Squamous Cell Cancer

China
Peking University

Unknown

mFOLFIRI as the Second Line Chemotherapy for Advanced Esophageal Carcinoma After Failure of 1st Line Treatment of Paclitaxel/DDP : a Phase II Single Center Prospective Clinical Trial

Advanced Esophageal Carcinoma

China
Peking University

Completed

Pneumatic Retinopexy Versus Vitrectomy With Gas for Retinal Detachment Due to Myopic Macular Hole (RDMH)

Retinal Detachment

China
Peking University

Recruiting

The Effect of MDT Plus SDM on Survival Benefit of Advanced Gastric Cancer

Gastric Cancer

China
Peking University

Recruiting

The Effectiveness of Group-Delivered Revised Guided Written Exposure Therapy for PTSD and Subclinical PTSD Among Chinese Adolescents

PTSD

China
Peking University

Recruiting

The Effects of Time Points to Cease Parenteral Nutrition and IGF-1 on Very Low Birth Weight Infants

Growth Retardation

China
Peking University

Not yet recruiting

Mechanisms of Mindfulness Intervention: Distress Tolerance Dose Manipulation

Emotional Disorder | Emotional Distress

China
Peking University

Recruiting

Phase 2 Trial of KN026+KN046±XELOX in HER2-positive Locally Advanced GC

HER2-positive Locally Advanced Resectable Gastric Cancer

China
Peking University

Recruiting

Study on the Mechanism of Eating Disorder

Anorexia Nervosa | Bulimia Nervosa

China
Peking University

Recruiting

A Modified Esophagogastric Reconstruction Method After Laparoscopic Proximal Gastrectomy

Proximal Gastric Adenocarcinoma | Anastomosis | Adenocarcinoma of Esophagogastric Junction

China
Peking University

Recruiting

To Evaluate the Efficacy and Safety of Afatinib for Advanced ALTRK-negative ESCC

Advanced Esophageal Squamous Cell Carcinoma

China
Peking University

Not yet recruiting

The Role of Cognitive Flexibility in Mindfulness Intervention for Emotional Distress

Emotional Distress

China
Peking University

Recruiting

The Effectiveness and Mechanism of Character Strengths-based STEP Programme on Rehabilitation of Stroke Patients (STEP)

Depression | Stroke | Rehabilitation | Intervention

China
Peking University

Not yet recruiting

Glaucoma Assessment Via Reading Ability

Glaucoma, Primary Open Angle
Peking University

Recruiting

Children to Adults Mental and Psychosomatic Health Study (CAMPS)

Cognitive Function | Mental Health Wellness | Physical Symptoms

China
Peking University

Recruiting

Plerixafor for Poorly Mobilized Lymphoma

Lymphoma

China
Peking University

Recruiting

Study on the Optimal Diagnosis and Treatment Strategy of Major Depressive Disorder Based on Anhedonia

Outpatients / Inpatients With Depression

China
Peking University

Not yet recruiting

Novel GPC3 CAR-T Cell Therapy for Hepatocellular Carcinoma
Peking University

Not yet recruiting

RD07 Cell Injection in the Treatment of Patients With Advanced Claudin18.2 Positive Solid Tumors

Solid Tumor
Peking University

Not yet recruiting

PTC in Personalizing Neoadjuvant Therapy for Patients With Advanced Gastrointestinal Tumor

Gastrointestinal Neoplasms
Peking University

Recruiting

Sintilimab Combined With IBI310 and Surufatinib for the Treatment of G3-NET and NEC

Neuroendocrine Neoplasm

China
Peking University

Recruiting

HAIC Combine With Lenvatinib and PD-1 Inhibitors for Advanced HCC With PVTT

Hepatocellular Carcinoma | Portal Vein Thrombosis

China
Peking University

Not yet recruiting

Study of CDK4/6 Inhibitor Combined With PD-L1 Monoclonal Antibody in the Treatment of PD-1/PD-L1 Resistance and Abnormal Cell Cycle Digestive System Tumors

Digestive System Tumors

China
Peking University

Recruiting

Trial of Surufatinib Combined With Toripalimab in the Treatment of Peritoneal Metastatic Carcinoma of Gastrointestinal or Primary Peritoneal Cancer

Primary Peritoneal Cancer | Refractory Metastatic Digestive System Carcinoma

China
Peking University

Recruiting

Biliary Drainage Plus HAIC in Locally Advanced pCCA

Perihilar Cholangiocarcinoma

China

3

Subscribe